Contact
searchSearch
HMP Global
Login

Infrastructure & Innovation

lightbulb
Infrastructure & Innovation
Details infrastructure for effective pathways, including, but not limited to coordination among pathway elements, data systems informatics/data architecture, AI and machine learning models, and data integration.

Original Research
Evaluating the Impact of EHR-Supported Tools and Workflows on Broad Panel Testing Rates for Patients With Metastatic Prostate Cancer in a Community Urology Practice
10/20/2026
Jeffrey Marotte, MD; Katie O'Brien, BS; Stacy McDonnel, BS; Urmi Bapat, MD; Joyce LaMori, MHS, MBA; Kristi Cohn, MHA; Phoebe Socha, BS; Ralph Jonathan Henderson, MD
This pilot study demonstrates how implementing an electronic health record (EHR)-supported, guideline-based care pathway can increase broad panel genetic testing rates among patients with metastatic prostate cancer in community oncology.
This pilot study demonstrates how implementing an electronic health record (EHR)-supported, guideline-based care pathway can increase broad panel genetic testing rates among patients with metastatic prostate cancer in community oncology.
This pilot study demonstrates...
10/20/2026
Journal of Clinical Pathways
From the Field
The Urology Prostate Cancer Note: A Tool to Enhance the Use of the Prostate Cancer Clinical Pathways
10/19/2026
Sarah Neveills, PhD, MS, RN; Michael Goodman, MD; Jeremy Shelton, MD, MSHS
This study examines how implementing a standardized urology clinical note within the US Department of Veterans Health system improved documentation of prostate cancer clinical pathways.
This study examines how implementing a standardized urology clinical note within the US Department of Veterans Health system improved documentation of prostate cancer clinical pathways.
This study examines how...
10/19/2026
Journal of Clinical Pathways
Transformative Business Trends
The Next Evolution of Employer Health Plans
10/16/2026
F. Randy Vogenberg, PhD, FASHP
This column examines how artificial intelligence, real-time analytics, and adaptive clinical pathways could shape 2027 benefit planning and simplify prior authorization.
This column examines how artificial intelligence, real-time analytics, and adaptive clinical pathways could shape 2027 benefit planning and simplify prior authorization.
This column examines how...
10/16/2026
Journal of Clinical Pathways
Transformative Business Trends
Medical Appropriateness and the Economics of Clinical Pathways
10/16/2026
F. Randy Vogenberg, PhD, FASHP
This column explores how clinical guidelines and pathways have evolved to support medical appropriateness, balance financial responsibility, and address growing challenges in health care access and affordability.
This column explores how clinical guidelines and pathways have evolved to support medical appropriateness, balance financial responsibility, and address growing challenges in health care access and affordability.
This column explores how...
10/16/2026
Journal of Clinical Pathways
Pharma Insights
Preparing for Oncology Pathway Placement Before and After Drug Launch
10/15/2026
Gordon Kuntz
This column explores how pharmaceutical manufacturers can incorporate clinical pathway strategies into oncology drug launch planning to improve treatment access and support preferred pathway placement.
This column explores how pharmaceutical manufacturers can incorporate clinical pathway strategies into oncology drug launch planning to improve treatment access and support preferred pathway placement.
This column explores how...
10/15/2026
Journal of Clinical Pathways
Original Research
Bispecific Antibody Treatments for Multiple Myeloma: A Hybrid Academic-Community Cancer Center’s Outpatient Step-up Dosing Care Model
02/17/2026
Christopher J. Ferreri, MD; Peter M. Voorhees, MD; Marvin Knight; Meaghan Roach, MPH; Richard Murphy, BA; Amal Jamaleddine, BA; Nicole Bariahtaris, BA; Cindy Varga, MD
This study demonstrates how a Hospital-at-Home–supported outpatient model can safely deliver step-up dosing of teclistamab and talquetamab for selected patients with relapsed/refractory multiple myeloma.
This study demonstrates how a Hospital-at-Home–supported outpatient model can safely deliver step-up dosing of teclistamab and talquetamab for selected patients with relapsed/refractory multiple myeloma.
This study demonstrates how a...
02/17/2026
Journal of Clinical Pathways
CPC+CBEx Conference Highlights
The View From the Stage: How AI, Data, and Pharmacist Leadership Drove Discussion at CPC+CBEx 2025
12/15/2025
Gordon Kuntz
Gordon Kuntz provides a recap of the 9th annual Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), highlighting important themes and notable sessions.
Gordon Kuntz provides a recap of the 9th annual Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), highlighting important themes and notable sessions.
Gordon Kuntz provides a recap of...
12/15/2025
Journal of Clinical Pathways
Original Research
Outpatient Care Model for Teclistamab Step-Up Dosing for the Treatment of Relapsed or Refractory Multiple Myeloma at OneOncology: Insights From a Managed Network of Independent Physician-Owned Community-Based Oncology Practices
12/15/2025
Lisa Raff, PharmD; Rozanne Wilson, PhD; Richard Murphy, BA; Amal Jamaleddine, BA; Nicole Bariahtaris, BA; Meaghan Roach, MPH
A community-derived playbook from OneOncology outlines practical strategies for delivering teclistamab step-up dosing in outpatient settings, enabling safer, more convenient access for patients.
A community-derived playbook from OneOncology outlines practical strategies for delivering teclistamab step-up dosing in outpatient settings, enabling safer, more convenient access for patients.
A community-derived playbook...
12/15/2025
Journal of Clinical Pathways
Conference Coverage
AI as a Thought Partner: Reframing Innovation in Medicine and Practice Management
09/09/2025
Grace Taylor, MS, MA
In this panel from CPC+CBEx, experts explore how artificial intelligence (AI) is emerging as a “thought partner” in health care, helping clinicians and practices manage rising complexity and improve outcomes while preserving the human touch...
In this panel from CPC+CBEx, experts explore how artificial intelligence (AI) is emerging as a “thought partner” in health care, helping clinicians and practices manage rising complexity and improve outcomes while preserving the human touch...
In this panel from CPC+CBEx,...
09/09/2025
Journal of Clinical Pathways
Conference Coverage
How AI is Reshaping Clinical Practice, Governance, and Patient Trust
09/09/2025
Grace Taylor, MS, MA
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation...
09/09/2025
Journal of Clinical Pathways

Current Issue

October 2026
Volume 12
Issue 4-5
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use